Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2022
/
Article
/
Tab 5
/
Research Article
Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer
Table 5
Comparison of serum LAPTM4B levels in BC patients between adjuvant therapy efficacy groups (median (IQR)).
Efficacy
Number
LAPTM4B (ng/mL)
value
PR + CR
196
7.39 (10.60)
0.004
PD + SD
134
10.39 (19.25)